Race Oncology Ltd
RAC
Company Profile
Business description
Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.
Contact
1 Macquarie Place
Level 36, Gateway
Sydney NSW 2000
AUST: +61 280513043
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
Stocks News & Analysis
stocks
Exploiting Warren Buffett
Growth investors are using Buffett to justify buying blue chip stocks at almost any price. It’s a recipe for potential disaster, as investors in market darlings like CBA and Cochlear may be about to find out.
stocks
Macquarie earnings go from great to mediocre
The outlook for the bank still looks good but are the shares attractive?
stocks
The cheapest ASX share on Morningstar’s Global Best Ideas list
The market is overly pessimistic about this 5-star opportunity.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,952.30 | 54.80 | 0.69% |
| CAC 40 | 7,957.57 | 42.92 | 0.54% |
| DAX 40 | 18,001.60 | 105.10 | 0.59% |
| Dow JONES (US) | 38,675.68 | 450.02 | 1.18% |
| FTSE 100 | 8,213.49 | 41.34 | 0.51% |
| HKSE | 18,561.46 | 85.54 | 0.46% |
| NASDAQ | 16,156.33 | 315.37 | 1.99% |
| Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
| NZX 50 Index | 11,820.78 | 117.30 | -0.98% |
| S&P 500 | 5,127.79 | 63.59 | 1.26% |
| S&P/ASX 200 | 7,682.40 | 53.40 | 0.70% |
| SSE Composite Index | 3,138.95 | 34.12 | 1.10% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| BrainChip Holdings Ltd BRN | 0.27 | 0.03 | 10.20% |
| Imugene Ltd IMU | 0.08 | 0.01 | -6.10% |
| The Star Entertainment Group Ltd SGR | 0.44 | 0.00 | 0.00% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Telstra Group Ltd TLS | 3.59 | 0.01 | 0.28% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.22% |
| Mesoblast Ltd MSB | 1.16 | 0.07 | 6.45% |
| South32 Ltd S32 | 3.62 | 0.04 | 1.12% |
| Endeavour Group Ltd EDV | 5.24 | 0.01 | 0.19% |
| AMP Ltd AMP | 1.10 | 0.03 | 2.82% |